Therapeutic and legal aspects of psilocybin in cancer-related depression

QR Code

Therapeutic and legal aspects of psilocybin in cancer-related depression

Depression prevalence is markedly elevated in oncological patients, particularly among head and neck cancer (HNC) cohorts, who face twice the prevalence of major depressive disorder (MDD) compared to other cancer populations. MDD in this context independently predicts poorer clinical outcomes and in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wierzbicka Małgorzata, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Psychiatry
Subjects:	head neck cancer treatment distress depression antidepressant utilization psilocybin
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1591864/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis
by: Haley D. M. Schuman, et al.
Published: (2025-06-01)

The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review
by: Charles Palmer, et al.
Published: (2025-05-01)

Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study
by: Luca Pellegrini, et al.
Published: (2025-10-01)

Chronic pain and depression. Correlation and treatment - A review of current literature
by: Barbara Wołoszyn, et al.
Published: (2025-07-01)

Effects of Psilocin and Psilocybin on Human 5-HT<sub>4</sub> Serotonin and H<sub>2</sub> Histamine Receptors in Perfused Hearts of Transgenic Mice
by: Pauline Braekow, et al.
Published: (2025-07-01)

Smoking, drinking, and depression: comorbidity in head and neck cancer patients undergoing radiotherapy
by: Kristen McCarter, et al.
Published: (2018-06-01)

Anxiety and depression in patients with head and neck cancer: 6-month follow-up study
by: Wu Y, et al.
Published: (2016-04-01)

THE CHOICE OF ANTIDEPRESSANTS FOR THE TREATMENT OF DEPRESSIVE DISORDERS ASSOCIATED WITH EPILEPSY
by: L. V. Lipatova, et al.
Published: (2016-12-01)

Use of the Hospital Anxiety and Depression Scale and the Taiwanese Depression Questionnaire for screening depression in head and neck cancer patients in Taiwan
by: Lee Y, et al.
Published: (2016-10-01)

THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY
by: Yu. V. Solomatin, et al.
Published: (2016-12-01)

Anhedonia as a basic syndrome and a target for treatment for depressive disorder
by: G. E. Mazo, et al.
Published: (2019-10-01)

ANXIETY AND DEPRESSION IN INTERNAL MEDICINE
by: A. V. Fedotova
Published: (2016-01-01)

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
by: Prasko J, et al.
Published: (2016-10-01)

Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings
by: Megan Calnan, et al.
Published: (2025-07-01)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
by: Novick D, et al.
Published: (2016-02-01)

Depressive disorders and their correction in complex treatment of metabolic syndrome patients
by: Yu. P. Uspensky, et al.
Published: (2007-06-01)

Medication non-adherence in depression: a systematic review and metanalysis
by: Roseane Dorte Halkjaer-Lassen, et al.
Published: (2025-07-01)

PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE
by: N. V. Ivanova, et al.
Published: (2015-12-01)

Depression and pain: some issues of comorbidity and treatment (Review)
by: Mamchur V., et al.
Published: (2011-01-01)

AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: N. Yu. Shimohina, et al.
Published: (2017-03-01)

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
by: Durgam S, et al.
Published: (2016-12-01)

Research trends in esketamine for depression over the past decade: a bibliometric analysis
by: Baozhou Zhang, et al.
Published: (2025-06-01)

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People&rsquo;s Republic of China
by: Zhang L, et al.
Published: (2016-04-01)

Cross-cultural pragmatics : the semantics of human interaction /
by: Wierzbicka, Anna
Published: (1991)

Semantics, culture, and cognition : universal human concepts in culture-specific configurations /
by: Wierzbicka, Anna
Published: (1992)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
by: Harada E, et al.
Published: (2016-01-01)

Depressive states in the structure of postcovid syndrome: features and therapy
by: N N Petrova, et al.
Published: (2022-04-01)

Correction of depressive-like state in rats induced by social stress using a new 3-substituted thietane-1,1-dioxide derivative
by: G. G. Gaisina, et al.
Published: (2025-03-01)

Symptom networks in major depressive disorder and treatment response: special focus on TRD
by: Alexander Kautzky, et al.
Published: (2025-01-01)

From the history of development of departments of medical service for head and neck tumors
by: P. V. Svetitsky, et al.
Published: (2024-04-01)

EFFICACY OF ANTIHYPERTENSIVE THERAPY WITH ADDED ANTIDEPRESSANT IN HYPERTENSION PATIENTS AND DEPRESSION
by: D. V. Kovalev, et al.
Published: (2016-06-01)

Cognitive impairments in patients with rheumatoid arthritis and comorbid anxiety and depressive disorders: Outcomes of the five-years prospective study
by: A. A. Abramkin, et al.
Published: (2024-11-01)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
by: L. K. Khokhlov, et al.
Published: (2019-05-01)

Researches of the imidazole and indole derivatives cerebroprotective activity and its impact on effects of antidepressants
by: I. I. Abramets, et al.
Published: (2020-07-01)

Radiation theraphy of head and neck cancer /
Published: (1989)

PSYCHOSOMATIC ASPECTS IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: V. I. Trofimov, et al.
Published: (2015-10-01)

COMPLIANCE TO LONG-TERM TREATMENT OF CARDIOLOGIC PATIENTS WITH MILD TO MODERATE DEPRESSION: INEFFECTIVENESS OF ANTIDEPRESSIVE THERAPY WITH PIRLINDOL IN RANDOMIZED STUDY
by: E. V. Strokova, et al.
Published: (2015-12-01)

Pregestational Stress Representing a Maternal Depression Model and Prenatally Applied Antidepressant Mirtazapine Modulate Hippocampal Excitability in Offspring
by: Lucia Dubiel-Hoppanova, et al.
Published: (2025-03-01)

The Use of Melatoninergic Antidepressants for Stabilization of Remission in Depression Comorbid with Alcohol Abuse, Anxiety or Neuropsychiatric Disorders: A Systematic Review
by: Svetlana G. Klimanova, et al.
Published: (2024-12-01)

Prospects of combined antihypertensive-psychocorrective therapy in women with arterial hypertension and anxiety-depressive disorders: clinical randomized placebo uncontrolled trial
by: V. V. Skibitskiy, et al.
Published: (2021-06-01)